Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marketa Hermanova

Showing results (41-50 of 53) with videos related to

Pageof 6
Sort By:
Journal of Oral Pathology & Medicine : Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology|August 7, 2018
Prognostic impact of combined immunoprofiles in oropharyngeal squamous cell carcinoma patients with respect to AJCC 8th editionDominik Gurin, Marek Slavik, Marketa Hermanova, et al.
Cancer Genomics & Proteomics|March 10, 2019
MicroRNA-15b-5p Predicts Locoregional Relapse in Head and Neck Carcinoma Patients Treated With Intensity-modulated RadiotherapyParwez Ahmad, Jiri Sana, Marek Slavik, et al.
Cellular Oncology (Dordrecht, Netherlands)|April 9, 2020
Salivary microRNAs identified by small RNA sequencing as potential predictors of response to intensity-modulated radiotherapy in head and neck cancer patientsParwez Ahmad, Marek Slavik, Karolina Trachtova, et al.
Head & Neck|December 16, 2018
Expression of CD44, EGFR, p16, and their mutual combinations in patients with head and neck cancer: Impact on outcomes of intensity-modulated radiation therapyMarek Slavik, Tetiana Shatokhina, Jiri Sana, et al.
Diagnostics (Basel, Switzerland)|January 21, 2023
Spinal Metastasis in a Patient with Supratentorial Glioblastoma with Primitive Neuronal Component: A Case Report with Clinical and Molecular EvaluationMichal Hendrych, Peter Solar, Marketa Hermanova, et al.
Diagnostic Pathology|April 25, 2015
MiR-21, miR-34a, miR-198 and miR-217 as diagnostic and prognostic biomarkers for chronic pancreatitis and pancreatic ductal adenocarcinomaPetra Vychytilova-Faltejskova, Igor Kiss, Sona Klusova, et al.
Carcinogenesis|October 18, 2014
Risk Score based on microRNA expression signature is independent prognostic classifier of glioblastoma patientsJiri Sana, Lenka Radova, Radek Lakomy, et al.
Epilepsia|August 18, 2023
Interictal high-frequency oscillations, spikes, and connectivity profiles: A fingerprint of epileptogenic brain pathologiesBarbora Sklenarova, Eva Zatloukalova, Jan Cimbalnik, et al.
Scientific Reports|December 17, 2025
Circulating MicroRNAs do not provide a diagnostic benefit over tissue biopsy in patients with brain metastasesMichaela Ruckova, Dagmar Al Tukmachi, Marek Vecera, et al.
Cancer Genomics & Proteomics|December 29, 2022
Small RNA Sequencing Identifies a Six-MicroRNA Signature Enabling Classification of Brain Metastases According to their OriginIvana Roskova, Marek Vecera, Lenka Radova, et al.
Pageof 6

Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
Journal of Oral Pathology & Medicine : Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology|August 7, 2018
Prognostic impact of combined immunoprofiles in oropharyngeal squamous cell carcinoma patients with respect to AJCC 8th editionDominik Gurin, Marek Slavik, Marketa Hermanova, et al.
Cancer Genomics & Proteomics|March 10, 2019
MicroRNA-15b-5p Predicts Locoregional Relapse in Head and Neck Carcinoma Patients Treated With Intensity-modulated RadiotherapyParwez Ahmad, Jiri Sana, Marek Slavik, et al.
Cellular Oncology (Dordrecht, Netherlands)|April 9, 2020
Salivary microRNAs identified by small RNA sequencing as potential predictors of response to intensity-modulated radiotherapy in head and neck cancer patientsParwez Ahmad, Marek Slavik, Karolina Trachtova, et al.
Head & Neck|December 16, 2018
Expression of CD44, EGFR, p16, and their mutual combinations in patients with head and neck cancer: Impact on outcomes of intensity-modulated radiation therapyMarek Slavik, Tetiana Shatokhina, Jiri Sana, et al.
Diagnostics (Basel, Switzerland)|January 21, 2023
Spinal Metastasis in a Patient with Supratentorial Glioblastoma with Primitive Neuronal Component: A Case Report with Clinical and Molecular EvaluationMichal Hendrych, Peter Solar, Marketa Hermanova, et al.
Diagnostic Pathology|April 25, 2015
MiR-21, miR-34a, miR-198 and miR-217 as diagnostic and prognostic biomarkers for chronic pancreatitis and pancreatic ductal adenocarcinomaPetra Vychytilova-Faltejskova, Igor Kiss, Sona Klusova, et al.
Carcinogenesis|October 18, 2014
Risk Score based on microRNA expression signature is independent prognostic classifier of glioblastoma patientsJiri Sana, Lenka Radova, Radek Lakomy, et al.
Epilepsia|August 18, 2023
Interictal high-frequency oscillations, spikes, and connectivity profiles: A fingerprint of epileptogenic brain pathologiesBarbora Sklenarova, Eva Zatloukalova, Jan Cimbalnik, et al.
Scientific Reports|December 17, 2025
Circulating MicroRNAs do not provide a diagnostic benefit over tissue biopsy in patients with brain metastasesMichaela Ruckova, Dagmar Al Tukmachi, Marek Vecera, et al.
Cancer Genomics & Proteomics|December 29, 2022
Small RNA Sequencing Identifies a Six-MicroRNA Signature Enabling Classification of Brain Metastases According to their OriginIvana Roskova, Marek Vecera, Lenka Radova, et al.
Pageof 6